Deen defended her fattening cooking style -- and her decision to keep her diabetes diagnosis a secret for three years -- to TODAY's Al Roker. "I have always encouraged moderation," she said. "I share with you all these yummy, fattening recipes, but I tell people, in moderation... it's entertainment. People have to be responsible."
Deen continued, "Like I told Oprah, 'Honey, I'm your cook, not your doctor.' You have to be responsible for yourself."
Ah, so when we eat a lot of fat and a lot of high-glycemic carbs, together, we're surprised by the outcome?
You're kidding, right? You have to be kidding.
Look, you can eat a lot of carbs, but then you better eat few to no fats. Or you can eat a lot of fats, but few to no carbs. If you eat both, well, you will get fat.
And you increase the risk of getting Type II Diabetes.
A lot.
So pick one. If you like your steak (and I do) then restrict the carbs. If you can't deal with being sans-pasta then get the damn fats out of your diet. Pick one and live that way, and while you're at it get your ass out of your chair and move!
But heh, that's not all! Deen kept her diagnosis secret for three years! Was that to allow some more pimping of donut-and-cheeseburgers on TV or was it so she could negotiate a nice fat deal with a pharma company to further exploit the morbidity of Americans?
That's a joke, right?
Oh wait... it's not.
The chef, who has come under fire in recent years for the unhealthy nature of many of her recipes, also announced that she is working as a paid spokesperson for the drug company Novo Nordisk, which manufactures Victoza - an injectable, non-insulin drug used in the treatment of type 2 diabetes.
Let's see, is the message this?
Don't worry sweetie, you can eat all the crap you want, sit on your ass all day, get as fat as you'd like, and then we'll fix it all with a nice little drug. (For a while, after which we won't talk about right now. Don't read the fine print; in your future are amputations, impotence and heart disease -- or worse -- along with a drained bank account.)
Where's the mention of the price of this drug? Let's see -- 1 box contains 2 "pens" (the drug is an injectable.) It lists out at about $350 per box at an average retail price. Each "pen" contains 18mg of drug and the unit delivers (in therapeutic use) either 1.2mg or 1.8mg per use, meaning that a "pen" lasts either 10 or 15 days. You get to inject yourself in the thigh or other "meaty" part of your body (that sounds quite entertaining, right?) and the drug itself requires refrigeration (isn't that nice!) If I'm reading the specs on this drug correctly one box will last either 20 or 30 days. Assuming you obtain therapeutic results from the lower dose that's $4,200 a year out of your pocket now and forever ($6,400 if you need the higher dose), since you're not going to change either what goes down the piehole or how often your ass comes out of your chair (if you had done that, and maybe if you do it now, you might not need the drug at all!)
You want to know why health insurance is $1,000/month? It might have something to do with drugs like this that come about due to demands for a "fix" to correct self-inflicted metabolic damage from those who don't want to write the personal checks that come with their behavior!
It doesn't stop there. The drug has a nice list of side effects, including a finding that it causes thyroid tumors -- malignant thyroid tumors -- in mice. Then there's the risk of renal failure (meaning dialysis in your future if you get unlucky on that), among other things.
But this is all entertainment, right, not to mention lots of profit for the drug companies that are really, really happy that you stuffed your pie hole and sat on your ass and instead of changing that they then get to sell you $350 worth of medication -- every month -- for however long you manage to continue to live.
Yeah, this is all very entertaining right up until your dick falls off, both your feet have to be amputated and you go blind. And that's if you don't get a bad dice roll and wind up with thyroid cancer (at which point they'll happily cut the tumor out of you which will then require you to take synthroid -- another expensive drug -- for the rest of your life!) or even worse, renal failure ("Hell", incidentally, has a synonym listed -- it's dialysis, which is what you'll be facing if that happens.)
Leave it to our wonderful media folks to not only lead you right up to the edge but then "partner" with a pharmaceutical company to profit (again) from the malaise that they helped induce.
If you want to know why I believe the entire putrid "health" industry needs to be literally razed and then fed into the wood chipper feet-first this sort of stunt is just the latest poster child example.

Discuss The Capital Markets along with daily technical analysis with our Gold Donor program.
Where We Are, Where We're Heading (2013) - The annual 2013 Ticker
The content on this site is provided without any warranty, express or implied. All opinions expressed on this site are those of the author and may contain errors or omissions.
NO MATERIAL HERE CONSTITUTES "INVESTMENT ADVICE" NOR IS IT A RECOMMENDATION TO BUY OR SELL ANY FINANCIAL INSTRUMENT, INCLUDING BUT NOT LIMITED TO STOCKS, OPTIONS, BONDS OR FUTURES.
The author may have a position in any company or security mentioned herein. Actions you undertake as a consequence of any analysis, opinion or advertisement on this site are your sole responsibility.
Looking for "The Best of Market Ticker"? Check out Ticker Classics.
Visit the forum to discuss this and other investing-related topics; see the FAQ on the forum for information about Gold Donor status including access to our technical analysis video server.
Market charts, when present, used with permission of TD Ameritrade/ThinkOrSwim Inc. Neither TD Ameritrade or ThinkOrSwim have reviewed, approved or disapproved any content herein.
Market Ticker content may be reproduced or excerpted online provided full attribution is given and the original article source is linked to. Please contact Karl Denninger for reprint permission in other media.
Submissions may be sent "over the transom" to The Editor at any time. To be considered for publication your submission must include full and correct contact information and be related to an economic or political matter of the day. All submissions become the property of The Market Ticker.
Leads on stories of current economic and political interest are always welcome. Our fax tip line is 850-897-9364; please include contact information with your transmission.